Cargando…
IPF Respiratory Symptoms Management — Current Evidence
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases. In this rev...
Autores principales: | Janowiak, Piotr, Szymanowska-Narloch, Amelia, Siemińska, Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368785/ https://www.ncbi.nlm.nih.gov/pubmed/35966835 http://dx.doi.org/10.3389/fmed.2022.917973 |
Ejemplares similares
-
Expiratory central airway collapse – an overlooked entity?: Two case reports
por: Janowiak, Piotr, et al.
Publicado: (2020) -
Senescent Cells in IPF: Locked in Repair?
por: Meiners, Silke, et al.
Publicado: (2020) -
Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
por: Skrzypski, Marcin, et al.
Publicado: (2017) -
Historical eye on IPF: a cohort study redefining the mortality scenario
por: Tomassetti, Sara, et al.
Publicado: (2023) -
Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)